Natural Alchemist
Letter data
- Company
- Natural Alchemist
- Recipient
- Natural Alchemist | United States
- Issue date
- 2018-07-03
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- 513852
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Natural Alchemist
MARCS-CMS 513852 —
July 03, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Natural Alchemist
United States
Issuing Office:
United States
1431 Harbor Bay Parkway
Alameda, CA 94502-7070
July 03, 2018
Mr. Will Claren, CEO
Natural Alchemist, Alurent Inc.
3941 Park Drive
El Dorado Hills, CA 95762
Dear Mr. Will Claren:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS # 513852), dated October 31, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Sergio Chavez, Director of Compliance
Office Human and Animal Foods
Division West 5
Content current as of:
07/09/2018